Coxopodopatellar syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1509OMIM:147891Q74.1
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Coxopodopatellar syndrome, also known as small patella syndrome or Scott-Taor syndrome, is a rare genetic skeletal disorder primarily affecting the bones and joints of the lower extremities and pelvis. The hallmark features include hypoplasia (underdevelopment) or aplasia (absence) of the patella (kneecap), abnormalities of the pelvis such as hypoplasia of the ischiopubic junction, and foot anomalies including wide gaps between the first and second toes and flat feet. The condition is classified under skeletal dysplasias with predominant involvement of the limbs. Affected individuals may experience difficulties with knee stability and mobility due to the absent or small patella, which can lead to recurrent patellar dislocations and knee pain. Pelvic abnormalities, particularly ischiopubic hypoplasia, are a distinctive radiographic finding. Additional skeletal features may include short stature and other minor limb anomalies. The condition is caused by mutations in the TBX4 gene, which encodes a transcription factor critical for limb and pelvic development. There is no cure for coxopodopatellar syndrome, and management is primarily supportive and symptomatic. Treatment may include physical therapy to strengthen the muscles around the knee, orthopedic interventions such as bracing for knee instability, and in some cases surgical procedures to address patellar instability or foot deformities. Regular orthopedic follow-up is recommended to monitor skeletal development, particularly during childhood and adolescence. Genetic counseling is advised for affected families given the hereditary nature of the condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Aplasia/Hypoplasia of the patellaHP:0006498
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

5 events
Mar 2026SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

Medipol University — NA

TrialRECRUITING
Jan 2026Extracorporeal Photopheresis (ECP) in the Treatment of Stiff Person Syndrome (OPTION Study)

Yandy Marx Castillo Aleman — EARLY_PHASE1

TrialNOT YET RECRUITING
Nov 2025A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Kyverna Therapeutics

TrialRECRUITING
Apr 2025Efgartigimod for Stiff Person Syndrome (ESPS)

University of South Florida — PHASE2

TrialNOT YET RECRUITING
Dec 2023SPACE (SPS ADVANCED CAGE): SPS Spacer for Intervertebral Fusion, Longitudinal, Prospective Clinical Study

SPS srl — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Coxopodopatellar syndrome.

View clinical trials →

No actively recruiting trials found for Coxopodopatellar syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Coxopodopatellar syndrome community →

Specialists

1 foundView all specialists →
MM
Mohamed Mamdouh Elsayed, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Coxopodopatellar syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Coxopodopatellar syndromeForum →

No community posts yet. Be the first to share your experience with Coxopodopatellar syndrome.

Start the conversation →

Latest news about Coxopodopatellar syndrome

Disease timeline:

New recruiting trial: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

A new clinical trial is recruiting patients for Coxopodopatellar syndrome

New recruiting trial: SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

A new clinical trial is recruiting patients for Coxopodopatellar syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Coxopodopatellar syndrome

What is Coxopodopatellar syndrome?

Coxopodopatellar syndrome, also known as small patella syndrome or Scott-Taor syndrome, is a rare genetic skeletal disorder primarily affecting the bones and joints of the lower extremities and pelvis. The hallmark features include hypoplasia (underdevelopment) or aplasia (absence) of the patella (kneecap), abnormalities of the pelvis such as hypoplasia of the ischiopubic junction, and foot anomalies including wide gaps between the first and second toes and flat feet. The condition is classified under skeletal dysplasias with predominant involvement of the limbs. Affected individuals may expe

How is Coxopodopatellar syndrome inherited?

Coxopodopatellar syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Coxopodopatellar syndrome typically begin?

Typical onset of Coxopodopatellar syndrome is childhood. Age of onset can vary across affected individuals.

Which specialists treat Coxopodopatellar syndrome?

1 specialists and care centers treating Coxopodopatellar syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.